Disease · MONDO_0002492
Comparisons in its trials55
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 55
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Hypotension Decision Support vs Usual Care Group: deaths from any cause | 158 of 4,972 | 534 of 17,463 | 22,435 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: serious adverse events | 541 of 4,972 | 1,811 of 17,463 | 22,435 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 50 mmHg for > 20 Minutes | 85 of 4,328 | 304 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Glycopyrrolate | 1,257 of 4,328 | 11,093 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Ephinephrine | 409 of 4,328 | 1,215 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 60 mmHg | 3,798 of 4,328 | 13,779 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 50 mmHg for > 10 Minutes | 326 of 4,328 | 1,159 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Phenylephrine | 3,685 of 4,328 | 12,211 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: In-hospital Mortality | 137 of 4,328 | 487 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 55 mmHg | 3,045 of 4,328 | 10,991 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Ephedrine | 2,718 of 4,328 | 9,310 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Norepinephrine | 233 of 4,328 | 762 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 60 mmHg for > 20 Minutes | 792 of 4,328 | 3,632 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 55 mmHg for > 10 Minutes | 759 of 4,328 | 3,181 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 55 mmHg for > 20 Minutes | 284 of 4,328 | 1,223 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 50 mmHg | 2,196 of 4,328 | 7,781 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 60 mmHg for > 10 Minutes | 1,723 of 4,328 | 6,989 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: 30-day Mortality | 143 of 1,285 | 511 of 4,667 | 5,952 | NCT02726620 | Trial comparisons |
| Statin vs Placebo: Number of Participants With Acute Kidney Injury | 64 of 308 | 60 of 307 | 615 | NCT00791648 | Trial comparisons |
| Statin vs Placebo: Number of Participants That Died | 4 of 308 | 1 of 307 | 615 | NCT00791648 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0002492/comparisons